Huangpu hosts inaugural cross-border pharmaceutical tour

The inaugural "Cross-Border Pharmaceutical Executives' Guangzhou Tour" recently took place on Guangzhou's International Bio-Island. 

The event gathered representatives from medical and health management departments in Guangdong, Hong Kong, and Macao, as well as executives from renowned pharmaceutical companies, such as Pfizer and Novo Nordisk.

The purpose of this event was to promote the integration of pharmaceutical supervision across the Guangdong-Hong Kong-Macao Greater Bay Area, promote the fusion of medical resources, and strengthen healthcare cooperation.

Thanks to Huangpu's efforts, Guangzhou is rapidly emerging as a vital base for the biopharmaceutical industry, housing over 4,000 biopharma companies. This event not only showcased Guangzhou's robust capabilities in the biopharmaceutical sector but also paved new ways for innovation and development in the regional pharmaceutical industry.